Matinas BioPharma Holdings
- Pharmaceutical Preparations
- Bedminster, New Jersey
Compensation history
Top executives at Matinas BioPharma Holdings received an average of $1M per person in annual compensation from 2014 to 2022.
Average pay of disclosed executives at Matinas BioPharma Holdings
By year
Executives
We found ten executives who work or worked at Matinas BioPharma Holdings.
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
James Ferguson
Matinas BioPharma Holdings
Chief Medical Officer
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
Keith Kucinski
Matinas BioPharma Holdings
Chief Financial Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019
About Matinas BioPharma Holdings
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address1545 Route 206 South, Suite 302, Bedminster, New Jersey 07921
- Phone908-484-8805
- Fiscal year endDecember 31
Source: SEC filings on September 19, 2023, September 22, 2022, October 1, 2020, September 24, 2018, September 14, 2017, and September 22, 2016.